Publication:
One-Year Follow-Up of Heroin-Dependent Adolescents Treated with Buprenorfine/Naloxone for the First Time in a Substance Treatment Unit

Simple item page
dc.contributor.authorMutlu, Caner
dc.contributor.authorDemirci, Arzu Ciftci
dc.contributor.authorYalcin, Ozhan
dc.contributor.authorKilicoglu, Ali Güven
dc.contributor.authorTopal, Melike
dc.contributor.authorKaracetin, Gul
dc.contributor.institutionauthorKILIÇOĞLU, ALİ GÜVEN
dc.date.accessioned2020-10-22T18:56:16Z
dc.date.available2020-10-22T18:56:16Z
dc.date.issued2016-08-01T00:00:00Z
dc.description.abstractThe aims of the present study were to evaluate 1-year retention in program and buprenorphine/naloxone (BUP/NAL) treatment,and abstinence of heroin-dependent adolescents. The present study included the follow-up information of 112 heroin dependent adolescents who took BUP/NAL treatment for the first time in a specific inpatient unit Retention and abstinence were assessed by self-report and urine drug screen at each visit. Mean age was 16.9 years, with 101 (90.2%) male. Program retention was 81.3% at day 30, and 24.1% at 1 year, while retention in BUP/NAL treatment was 69.6% at day 30 and 16.1% at 1 year. Rates of abstinence were 69.0% at day 30 and 10.3% at 1 year. There was a significant positive correlation between duration of inpatient treatment and program retention, treatment retention, abstinence (p < 0.05 for all), and between the dose and treatment retention, abstinence (p < 0.05 for both). Patients with comorbid psychiatric disease were more likely to be retained in treatment for 3 months, and in program for 6 months (p < 0.05, for all). Patients who completed inpatient treatment were more likely to be retained in treatment for 1 year, and in program for 9 months, and to be abstinent for 1 year (p < 0.05, for all). Findings suggested that starting BUP/NAL treatment in an inpatient unit might result in better outcomes compared to literature. Duration of inpatient treatment, the completion of inpatient treatment, BUP/NAL dose, and having a comorbid psychiatric disease seemed to be important factors for heroin-dependent adolescents in retention and abstinence within 1-year period. (C) 2016 Elsevier Inc. All rights reserved.
dc.identifier.citationMutlu C., Demirci A. C. , Yalcin O., Kilicoglu A. G. , Topal M., Karacetin G., -One-Year Follow-Up of Heroin-Dependent Adolescents Treated with Buprenorfine/Naloxone for the First Time in a Substance Treatment Unit-, JOURNAL OF SUBSTANCE ABUSE TREATMENT, cilt.67, ss.1-8, 2016
dc.identifier.doi10.1016/j.jsat.2016.04.002
dc.identifier.scopus84968799783
dc.identifier.urihttp://hdl.handle.net/20.500.12645/24373
dc.identifier.wosWOS:000378465800001
dc.titleOne-Year Follow-Up of Heroin-Dependent Adolescents Treated with Buprenorfine/Naloxone for the First Time in a Substance Treatment Unit
dc.typeArticle
dspace.entity.typePublication
local.avesis.ida78b9c2e-3f19-43ea-8858-37fa23ad523b
local.publication.isinternational1
relation.isAuthorOfPublicationddba8e48-9ba3-4155-80ba-3c8e044a5419
relation.isAuthorOfPublication.latestForDiscoveryddba8e48-9ba3-4155-80ba-3c8e044a5419
Files
Collections
Silinecekler